Moon MJ, Lee YN, Park S, Reyes-Alcaraz A, Hwang JI, Millar RP, et al
Can Boost Energy Semaglutide does not directly enhance energy levels
The launch of generic liraglutide (Teva, August 2025) and anticipated oral GLP-1 options (oral Wegovy approved December 2025, orforglipron pending) offer lower-cost alternatives that may simplify pharmacy benefit management
Recommend some remedies for clients who are having GI side effects, but let them know that the side effects vary and likely will be transient
Os riscos concretos do uso desses produtos irregulares incluem: dose desconhecida e sem padronizao, ausncia de garantia de esterilidade e pureza, risco de contaminao, falta de rastreabilidade e de farmacovigilncia, possibilidade de eventos adversos graves, sem suporte assistencial adequado